B BRAUN MEDICAL INC Company Profile

✉ Email this page to a colleague

B BRAUN MEDICAL INC has eleven approved drugs.

There are two US patents protecting B BRAUN MEDICAL INC drugs.

There are twenty-seven patent family members on B BRAUN MEDICAL INC drugs in twenty-seven countries and fifty-nine supplementary protection certificates in fifteen countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun Medical Inc	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	208475-001	Sep 8, 2021	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun Medical Inc	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	207966-001	Oct 27, 2020	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun Medical Inc	LIDOCAINE HYDROCHLORIDE	lidocaine hydrochloride	INJECTABLE;INJECTION	208474-001	Aug 3, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun Medical Inc	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	209705-001	Feb 27, 2024	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun Medical Inc	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	209705-003	Feb 27, 2024	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun Medical Inc	MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	meropenem	POWDER;INTRAVENOUS	202106-001	Apr 30, 2015		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2957286	132019000000021	Italy	⤷ Try a Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM E QUALSIASI SUO SALE O DERIVATO(VELTASSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1179, 20170721
1499331	SPC/GB13/034	United Kingdom	⤷ Try a Trial	PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313
2957286	1990003-4	Sweden	⤷ Try a Trial	PRODUCT NAME: PATRIOMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179 20170721
0124495	SPC/GB01/006	United Kingdom	⤷ Try a Trial	PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
2957286	CA 2018 00043	Denmark	⤷ Try a Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179/001-009 20170721
2365988	122018000012	Germany	⤷ Try a Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.